Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability

Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 (TARDBP) in familial ALS confirms a mechanistic link betwee...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2012-04, Vol.109 (15), p.5803-5808
Hauptverfasser: Bilican, Bilada, Serio, Andrea, Barmada, Sami J, Nishimura, Agnes Lumi, Sullivan, Gareth J, Carrasco, Monica, Phatnani, Hemali P, Puddifoot, Clare A, Story, David, Fletcher, Judy, Park, In-Hyun, Friedman, Brad A, Daley, George Q, Wyllie, David J. A, Hardingham, Giles E, Wilmut, Ian, Finkbeiner, Steven, Maniatis, Tom, Shaw, Christopher E, Chandran, Siddharthan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5808
container_issue 15
container_start_page 5803
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 109
creator Bilican, Bilada
Serio, Andrea
Barmada, Sami J
Nishimura, Agnes Lumi
Sullivan, Gareth J
Carrasco, Monica
Phatnani, Hemali P
Puddifoot, Clare A
Story, David
Fletcher, Judy
Park, In-Hyun
Friedman, Brad A
Daley, George Q
Wyllie, David J. A
Hardingham, Giles E
Wilmut, Ian
Finkbeiner, Steven
Maniatis, Tom
Shaw, Christopher E
Chandran, Siddharthan
description Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 (TARDBP) in familial ALS confirms a mechanistic link between misaccumulation of TDP-43 and neurodegeneration and provides an opportunity to study TDP-43 proteinopathies in human neurons generated from patient fibroblasts by using induced pluripotent stem cells (iPSCs). Here, we report the generation of iPSCs that carry the TDP-43 M337V mutation and their differentiation into neurons and functional motor neurons. Mutant neurons had elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway. We conclude that expression of physiological levels of TDP-43 in human neurons is sufficient to reveal a mutation-specific cell-autonomous phenotype and strongly supports this approach for the study of disease mechanisms and for drug screening.
doi_str_mv 10.1073/pnas.1202922109
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1999946989</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>41588246</jstor_id><sourcerecordid>41588246</sourcerecordid><originalsourceid>FETCH-LOGICAL-c589t-43db461b4f0a87902b25d0a798188d0dbed2112bd85fbcf295dfb57263ed88353</originalsourceid><addsrcrecordid>eNqFks9vFCEUx4nR2G317EklnrxM-2BgBi4mpv5MajSxPRNmYFo27DACs0lv_ull3HWrXuQACXy-3_B97yH0jMApgbY-m0adTgkFKiklIB-gVdlJ1TAJD9EKgLaVYJQdoeOU1gAguYDH6IhSxokEuUI_v8xZjxm70cy9NXjyc3RTyLbcpWw3uLfeY-9Gm3C0vZ5cnr3OFus02T4nHAZ8-e5bxWo8xSJzY5h0vnEF16Mpkq3V_pdJtQjc4Hq8nf1oo-6cd_n2CXo0aJ_s0_15gq4-vL88_1RdfP34-fztRdVzIXPxNx1rSMcG0KKVQDvKDehWCiKEAdNZQwmhnRF86PqBSm6Gjre0qa0Roub1CXqz853mbmNNXwJG7dUU3UbHWxW0U3-_jO5GXYetqmvasKYuBq_3BjH8mG3KauPSEkyPNsxJEVkWa6SQ_0dLJxg0RIqCvvoHXYc5jqUSqriVFrUUCnS2g_oYUop2OHybgFrmQC1zoO7noChe_Jn2wP9ufAFe7oFFeW8nFeGqDMmS9_mOWKcc4gFhhAtBS0EODoMOSl9Hl9TVdwqElXCCsIbXd_9nzgE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>994909720</pqid></control><display><type>article</type><title>Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Bilican, Bilada ; Serio, Andrea ; Barmada, Sami J ; Nishimura, Agnes Lumi ; Sullivan, Gareth J ; Carrasco, Monica ; Phatnani, Hemali P ; Puddifoot, Clare A ; Story, David ; Fletcher, Judy ; Park, In-Hyun ; Friedman, Brad A ; Daley, George Q ; Wyllie, David J. A ; Hardingham, Giles E ; Wilmut, Ian ; Finkbeiner, Steven ; Maniatis, Tom ; Shaw, Christopher E ; Chandran, Siddharthan</creator><creatorcontrib>Bilican, Bilada ; Serio, Andrea ; Barmada, Sami J ; Nishimura, Agnes Lumi ; Sullivan, Gareth J ; Carrasco, Monica ; Phatnani, Hemali P ; Puddifoot, Clare A ; Story, David ; Fletcher, Judy ; Park, In-Hyun ; Friedman, Brad A ; Daley, George Q ; Wyllie, David J. A ; Hardingham, Giles E ; Wilmut, Ian ; Finkbeiner, Steven ; Maniatis, Tom ; Shaw, Christopher E ; Chandran, Siddharthan</creatorcontrib><description>Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 (TARDBP) in familial ALS confirms a mechanistic link between misaccumulation of TDP-43 and neurodegeneration and provides an opportunity to study TDP-43 proteinopathies in human neurons generated from patient fibroblasts by using induced pluripotent stem cells (iPSCs). Here, we report the generation of iPSCs that carry the TDP-43 M337V mutation and their differentiation into neurons and functional motor neurons. Mutant neurons had elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway. We conclude that expression of physiological levels of TDP-43 in human neurons is sufficient to reveal a mutation-specific cell-autonomous phenotype and strongly supports this approach for the study of disease mechanisms and for drug screening.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.1202922109</identifier><identifier>PMID: 22451909</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Adult ; Amyotrophic lateral sclerosis ; Binding sites ; Biological Sciences ; Cell Differentiation ; Cell Differentiation - drug effects ; Cell lines ; Detergents ; Detergents - pharmacology ; Disease models ; DNA-Binding Proteins ; DNA-Binding Proteins - metabolism ; drug effects ; drugs ; Female ; fibroblasts ; Fibroblasts - drug effects ; Fibroblasts - metabolism ; Fibroblasts - pathology ; genes ; Genetic mutation ; genetics ; Humans ; Induced Pluripotent Stem Cells ; Induced Pluripotent Stem Cells - drug effects ; Induced Pluripotent Stem Cells - metabolism ; longitudinal studies ; Male ; metabolism ; Middle Aged ; Motor neurons ; Motor Neurons - drug effects ; Motor Neurons - metabolism ; Motor Neurons - pathology ; mutants ; Mutation ; Mutation - genetics ; Nervous system diseases ; Neurodegenerative diseases ; Neurons ; Organ Specificity ; Organ Specificity - drug effects ; pathology ; patients ; pharmacology ; phenotype ; phosphatidylinositol 3-kinase ; Proteins ; sclerosis ; screening ; Solubility ; Solubility - drug effects ; Stem cells ; TDP-43 Proteinopathies ; TDP-43 Proteinopathies - genetics</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2012-04, Vol.109 (15), p.5803-5808</ispartof><rights>copyright © 1993-2008 National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences Apr 10, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c589t-43db461b4f0a87902b25d0a798188d0dbed2112bd85fbcf295dfb57263ed88353</citedby><cites>FETCH-LOGICAL-c589t-43db461b4f0a87902b25d0a798188d0dbed2112bd85fbcf295dfb57263ed88353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/109/15.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/41588246$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/41588246$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,725,778,782,801,883,27907,27908,53774,53776,58000,58233</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22451909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bilican, Bilada</creatorcontrib><creatorcontrib>Serio, Andrea</creatorcontrib><creatorcontrib>Barmada, Sami J</creatorcontrib><creatorcontrib>Nishimura, Agnes Lumi</creatorcontrib><creatorcontrib>Sullivan, Gareth J</creatorcontrib><creatorcontrib>Carrasco, Monica</creatorcontrib><creatorcontrib>Phatnani, Hemali P</creatorcontrib><creatorcontrib>Puddifoot, Clare A</creatorcontrib><creatorcontrib>Story, David</creatorcontrib><creatorcontrib>Fletcher, Judy</creatorcontrib><creatorcontrib>Park, In-Hyun</creatorcontrib><creatorcontrib>Friedman, Brad A</creatorcontrib><creatorcontrib>Daley, George Q</creatorcontrib><creatorcontrib>Wyllie, David J. A</creatorcontrib><creatorcontrib>Hardingham, Giles E</creatorcontrib><creatorcontrib>Wilmut, Ian</creatorcontrib><creatorcontrib>Finkbeiner, Steven</creatorcontrib><creatorcontrib>Maniatis, Tom</creatorcontrib><creatorcontrib>Shaw, Christopher E</creatorcontrib><creatorcontrib>Chandran, Siddharthan</creatorcontrib><title>Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 (TARDBP) in familial ALS confirms a mechanistic link between misaccumulation of TDP-43 and neurodegeneration and provides an opportunity to study TDP-43 proteinopathies in human neurons generated from patient fibroblasts by using induced pluripotent stem cells (iPSCs). Here, we report the generation of iPSCs that carry the TDP-43 M337V mutation and their differentiation into neurons and functional motor neurons. Mutant neurons had elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway. We conclude that expression of physiological levels of TDP-43 in human neurons is sufficient to reveal a mutation-specific cell-autonomous phenotype and strongly supports this approach for the study of disease mechanisms and for drug screening.</description><subject>Adult</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Binding sites</subject><subject>Biological Sciences</subject><subject>Cell Differentiation</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell lines</subject><subject>Detergents</subject><subject>Detergents - pharmacology</subject><subject>Disease models</subject><subject>DNA-Binding Proteins</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>drug effects</subject><subject>drugs</subject><subject>Female</subject><subject>fibroblasts</subject><subject>Fibroblasts - drug effects</subject><subject>Fibroblasts - metabolism</subject><subject>Fibroblasts - pathology</subject><subject>genes</subject><subject>Genetic mutation</subject><subject>genetics</subject><subject>Humans</subject><subject>Induced Pluripotent Stem Cells</subject><subject>Induced Pluripotent Stem Cells - drug effects</subject><subject>Induced Pluripotent Stem Cells - metabolism</subject><subject>longitudinal studies</subject><subject>Male</subject><subject>metabolism</subject><subject>Middle Aged</subject><subject>Motor neurons</subject><subject>Motor Neurons - drug effects</subject><subject>Motor Neurons - metabolism</subject><subject>Motor Neurons - pathology</subject><subject>mutants</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>Nervous system diseases</subject><subject>Neurodegenerative diseases</subject><subject>Neurons</subject><subject>Organ Specificity</subject><subject>Organ Specificity - drug effects</subject><subject>pathology</subject><subject>patients</subject><subject>pharmacology</subject><subject>phenotype</subject><subject>phosphatidylinositol 3-kinase</subject><subject>Proteins</subject><subject>sclerosis</subject><subject>screening</subject><subject>Solubility</subject><subject>Solubility - drug effects</subject><subject>Stem cells</subject><subject>TDP-43 Proteinopathies</subject><subject>TDP-43 Proteinopathies - genetics</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks9vFCEUx4nR2G317EklnrxM-2BgBi4mpv5MajSxPRNmYFo27DACs0lv_ull3HWrXuQACXy-3_B97yH0jMApgbY-m0adTgkFKiklIB-gVdlJ1TAJD9EKgLaVYJQdoeOU1gAguYDH6IhSxokEuUI_v8xZjxm70cy9NXjyc3RTyLbcpWw3uLfeY-9Gm3C0vZ5cnr3OFus02T4nHAZ8-e5bxWo8xSJzY5h0vnEF16Mpkq3V_pdJtQjc4Hq8nf1oo-6cd_n2CXo0aJ_s0_15gq4-vL88_1RdfP34-fztRdVzIXPxNx1rSMcG0KKVQDvKDehWCiKEAdNZQwmhnRF86PqBSm6Gjre0qa0Roub1CXqz853mbmNNXwJG7dUU3UbHWxW0U3-_jO5GXYetqmvasKYuBq_3BjH8mG3KauPSEkyPNsxJEVkWa6SQ_0dLJxg0RIqCvvoHXYc5jqUSqriVFrUUCnS2g_oYUop2OHybgFrmQC1zoO7noChe_Jn2wP9ufAFe7oFFeW8nFeGqDMmS9_mOWKcc4gFhhAtBS0EODoMOSl9Hl9TVdwqElXCCsIbXd_9nzgE</recordid><startdate>20120410</startdate><enddate>20120410</enddate><creator>Bilican, Bilada</creator><creator>Serio, Andrea</creator><creator>Barmada, Sami J</creator><creator>Nishimura, Agnes Lumi</creator><creator>Sullivan, Gareth J</creator><creator>Carrasco, Monica</creator><creator>Phatnani, Hemali P</creator><creator>Puddifoot, Clare A</creator><creator>Story, David</creator><creator>Fletcher, Judy</creator><creator>Park, In-Hyun</creator><creator>Friedman, Brad A</creator><creator>Daley, George Q</creator><creator>Wyllie, David J. A</creator><creator>Hardingham, Giles E</creator><creator>Wilmut, Ian</creator><creator>Finkbeiner, Steven</creator><creator>Maniatis, Tom</creator><creator>Shaw, Christopher E</creator><creator>Chandran, Siddharthan</creator><general>National Academy of Sciences</general><general>National Acad Sciences</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope></search><sort><creationdate>20120410</creationdate><title>Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability</title><author>Bilican, Bilada ; Serio, Andrea ; Barmada, Sami J ; Nishimura, Agnes Lumi ; Sullivan, Gareth J ; Carrasco, Monica ; Phatnani, Hemali P ; Puddifoot, Clare A ; Story, David ; Fletcher, Judy ; Park, In-Hyun ; Friedman, Brad A ; Daley, George Q ; Wyllie, David J. A ; Hardingham, Giles E ; Wilmut, Ian ; Finkbeiner, Steven ; Maniatis, Tom ; Shaw, Christopher E ; Chandran, Siddharthan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c589t-43db461b4f0a87902b25d0a798188d0dbed2112bd85fbcf295dfb57263ed88353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Binding sites</topic><topic>Biological Sciences</topic><topic>Cell Differentiation</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell lines</topic><topic>Detergents</topic><topic>Detergents - pharmacology</topic><topic>Disease models</topic><topic>DNA-Binding Proteins</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>drug effects</topic><topic>drugs</topic><topic>Female</topic><topic>fibroblasts</topic><topic>Fibroblasts - drug effects</topic><topic>Fibroblasts - metabolism</topic><topic>Fibroblasts - pathology</topic><topic>genes</topic><topic>Genetic mutation</topic><topic>genetics</topic><topic>Humans</topic><topic>Induced Pluripotent Stem Cells</topic><topic>Induced Pluripotent Stem Cells - drug effects</topic><topic>Induced Pluripotent Stem Cells - metabolism</topic><topic>longitudinal studies</topic><topic>Male</topic><topic>metabolism</topic><topic>Middle Aged</topic><topic>Motor neurons</topic><topic>Motor Neurons - drug effects</topic><topic>Motor Neurons - metabolism</topic><topic>Motor Neurons - pathology</topic><topic>mutants</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>Nervous system diseases</topic><topic>Neurodegenerative diseases</topic><topic>Neurons</topic><topic>Organ Specificity</topic><topic>Organ Specificity - drug effects</topic><topic>pathology</topic><topic>patients</topic><topic>pharmacology</topic><topic>phenotype</topic><topic>phosphatidylinositol 3-kinase</topic><topic>Proteins</topic><topic>sclerosis</topic><topic>screening</topic><topic>Solubility</topic><topic>Solubility - drug effects</topic><topic>Stem cells</topic><topic>TDP-43 Proteinopathies</topic><topic>TDP-43 Proteinopathies - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bilican, Bilada</creatorcontrib><creatorcontrib>Serio, Andrea</creatorcontrib><creatorcontrib>Barmada, Sami J</creatorcontrib><creatorcontrib>Nishimura, Agnes Lumi</creatorcontrib><creatorcontrib>Sullivan, Gareth J</creatorcontrib><creatorcontrib>Carrasco, Monica</creatorcontrib><creatorcontrib>Phatnani, Hemali P</creatorcontrib><creatorcontrib>Puddifoot, Clare A</creatorcontrib><creatorcontrib>Story, David</creatorcontrib><creatorcontrib>Fletcher, Judy</creatorcontrib><creatorcontrib>Park, In-Hyun</creatorcontrib><creatorcontrib>Friedman, Brad A</creatorcontrib><creatorcontrib>Daley, George Q</creatorcontrib><creatorcontrib>Wyllie, David J. A</creatorcontrib><creatorcontrib>Hardingham, Giles E</creatorcontrib><creatorcontrib>Wilmut, Ian</creatorcontrib><creatorcontrib>Finkbeiner, Steven</creatorcontrib><creatorcontrib>Maniatis, Tom</creatorcontrib><creatorcontrib>Shaw, Christopher E</creatorcontrib><creatorcontrib>Chandran, Siddharthan</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bilican, Bilada</au><au>Serio, Andrea</au><au>Barmada, Sami J</au><au>Nishimura, Agnes Lumi</au><au>Sullivan, Gareth J</au><au>Carrasco, Monica</au><au>Phatnani, Hemali P</au><au>Puddifoot, Clare A</au><au>Story, David</au><au>Fletcher, Judy</au><au>Park, In-Hyun</au><au>Friedman, Brad A</au><au>Daley, George Q</au><au>Wyllie, David J. A</au><au>Hardingham, Giles E</au><au>Wilmut, Ian</au><au>Finkbeiner, Steven</au><au>Maniatis, Tom</au><au>Shaw, Christopher E</au><au>Chandran, Siddharthan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2012-04-10</date><risdate>2012</risdate><volume>109</volume><issue>15</issue><spage>5803</spage><epage>5808</epage><pages>5803-5808</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 (TARDBP) in familial ALS confirms a mechanistic link between misaccumulation of TDP-43 and neurodegeneration and provides an opportunity to study TDP-43 proteinopathies in human neurons generated from patient fibroblasts by using induced pluripotent stem cells (iPSCs). Here, we report the generation of iPSCs that carry the TDP-43 M337V mutation and their differentiation into neurons and functional motor neurons. Mutant neurons had elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway. We conclude that expression of physiological levels of TDP-43 in human neurons is sufficient to reveal a mutation-specific cell-autonomous phenotype and strongly supports this approach for the study of disease mechanisms and for drug screening.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>22451909</pmid><doi>10.1073/pnas.1202922109</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2012-04, Vol.109 (15), p.5803-5808
issn 0027-8424
1091-6490
language eng
recordid cdi_proquest_miscellaneous_1999946989
source MEDLINE; Jstor Complete Legacy; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Adult
Amyotrophic lateral sclerosis
Binding sites
Biological Sciences
Cell Differentiation
Cell Differentiation - drug effects
Cell lines
Detergents
Detergents - pharmacology
Disease models
DNA-Binding Proteins
DNA-Binding Proteins - metabolism
drug effects
drugs
Female
fibroblasts
Fibroblasts - drug effects
Fibroblasts - metabolism
Fibroblasts - pathology
genes
Genetic mutation
genetics
Humans
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells - drug effects
Induced Pluripotent Stem Cells - metabolism
longitudinal studies
Male
metabolism
Middle Aged
Motor neurons
Motor Neurons - drug effects
Motor Neurons - metabolism
Motor Neurons - pathology
mutants
Mutation
Mutation - genetics
Nervous system diseases
Neurodegenerative diseases
Neurons
Organ Specificity
Organ Specificity - drug effects
pathology
patients
pharmacology
phenotype
phosphatidylinositol 3-kinase
Proteins
sclerosis
screening
Solubility
Solubility - drug effects
Stem cells
TDP-43 Proteinopathies
TDP-43 Proteinopathies - genetics
title Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A05%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mutant%20induced%20pluripotent%20stem%20cell%20lines%20recapitulate%20aspects%20of%20TDP-43%20proteinopathies%20and%20reveal%20cell-specific%20vulnerability&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Bilican,%20Bilada&rft.date=2012-04-10&rft.volume=109&rft.issue=15&rft.spage=5803&rft.epage=5808&rft.pages=5803-5808&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.1202922109&rft_dat=%3Cjstor_proqu%3E41588246%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=994909720&rft_id=info:pmid/22451909&rft_jstor_id=41588246&rfr_iscdi=true